Lista de obras - Grażyna Gromadzka - Dominio Público Uruguay

APOE does not predict poor outcome 1 year after ischemic stroke

artículo científico publicado en 2007

APOE genotype and serum cholesterol in predicting risk for early death from ischemic stroke in men and women.

artículo científico publicado en 2005

APOE ϵ 2 allele is an independent risk factor for vulnerable carotid plaque in ischemic stroke patients

scientific article published on 20 May 2014

Apolipoprotein E (APOE) gene polymorphism and risk and prognosis in cerebral amyloid angiopathy-related haemorrhage ⬇️

artículo científico publicado el 1 de noviembre de 2010

Apolipoprotein E gene (APOE) genotype in Wilson's disease: impact on clinical presentation.

artículo científico publicado en 2012

Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals

artículo científico publicado en 2013

Association between BDNF-196 G>A and BDNF-270 C>T polymorphisms, BDNF concentration, and rTMS-supported long-term rehabilitation outcome after ischemic stroke.

artículo científico publicado en 2013

Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-α polymorphisms with risk and clinical course of multiple sclerosis in a Polish population

scientific article published on 31 May 2011

Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population

artículo científico publicado en 2009

Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease ⬇️

artículo científico publicado en 2012

BDNF -270 C>T polymorphisms might be associated with stroke type and BDNF -196 G>A corresponds to early neurological deficit in hemorrhagic stroke

artículo científico publicado en 2012

BDNF A196G and C270T gene polymorphisms and susceptibility to multiple sclerosis in the Polish population. Gender differences

artículo científico publicado en 2007

Brain metal accumulation in Wilson's disease.

artículo científico publicado en 2013

CADASIL patient with extracellular calcium deposits

artículo científico publicado en 2013

Ceruloplasmin, hephaestin and zyklopen: the three multicopper oxidases important for human iron metabolism

artículo científico publicado en 2014

Clinical features of hemolysis, elevated liver enzymes, and low platelet count syndrome in undiagnosed Wilson disease: report of two cases.

artículo científico publicado en 2009

Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications

scientific article published on 04 December 2020

Difference in iron metabolism may partly explain sex-related variability in the manifestation of Wilson's disease

scientific article published on 28 August 2020

Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.

artículo científico publicado en 2014

Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease.

artículo científico publicado en 2003

Dysfunctional proteins in neuropsychiatric disorders: from neurodegeneration to Autism Spectrum Disorders

artículo científico publicado en 2020

Echolucent internal carotid artery plaques are a risk factor for stroke

scientific article published on 01 March 2008

Effect of homeostatic iron regulator protein gene mutation on Wilson's disease clinical manifestation: original data and literature review

artículo científico publicado en 2020

Elevated levels of anti-heat shock protein antibodies in patients with cerebral ischemia.

artículo científico publicado en 2001

Erratum to: Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease.

artículo científico publicado en 2014

Estrogen and cytokines production - the possible cause of gender differences in neurological diseases.

artículo científico publicado en 2005

Evaluation of the microplate enzyme-linked assay with isolation of glycoprotein IIb/IIIa from platelet membranes: comparison with immunofluorescent tests and monoclonal antibodies

artículo científico publicado en 1993

Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease.

artículo científico publicado en 2005

Frequency of His1069Gln and Gly1267Lys mutations in Polish Wilson's disease population

artículo científico publicado en 2000

Gender differences in Wilson's disease

artículo científico publicado en 2011

Gender differences in neurological disease: role of estrogens and cytokines

artículo científico publicado en 2006

Gene variants encoding proteins involved in antioxidant defense system and the clinical expression of Wilson disease

artículo científico publicado en 2014

Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson's disease

artículo científico publicado en 2011

Heterozygous carriers for Wilson's disease--magnetic spectroscopy changes in the brain.

artículo científico publicado en 2009

IL1RN intron 2 polymorphism caused by variable number tandem repeats is associated with 1-year outcome in patients with ischaemic stroke.

artículo científico publicado en 2006

Impact of BDNF -196 G>A and BDNF -270 C>T polymorphisms on stroke rehabilitation outcome: sex and age differences.

artículo científico publicado en 2014

Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus

artículo científico publicado en 2002

Infections and ischemic stroke outcome.

artículo científico publicado en 2011

Influence of BDNF polymorphisms on Wilson's disease susceptibility and clinical course

scientific article published on 22 March 2013

Influence of IL-1RN intron 2 variable number of tandem repeats (VNTR) polymorphism on the age at onset of neuropsychiatric symptoms in Wilson's disease.

artículo científico publicado en 2010

Influence of age and gender on cytokine expression in a murine model of Parkinson's disease

artículo científico publicado en 2007

Intestinal expression of metal transporters in Wilson's disease.

artículo científico publicado en 2013

Late onset Wilson's disease: therapeutic implications

artículo científico publicado en 2008

Late-onset Wilson's disease

artículo científico publicado en 2007

Liver cirrhosis in patients newly diagnosed with neurological phenotype of Wilson's disease

artículo científico publicado en 2014

Long-term effect of high doses glucocorticosteroids on mRNA expression for IL-6 and IL-8 in relapsed multiple sclerosis patients

artículo científico publicado en 2010

Middle-aged heterozygous carriers of Wilson's disease do not present with significant phenotypic deviations related to copper metabolism

artículo científico publicado en 2010

Monozygotic female twins discordant for phenotype of Wilson's disease

artículo científico publicado en 2009

Neurochemical and behavioral characteristics of toxic milk mice: an animal model of Wilson's disease.

artículo científico publicado en 2013

Neurological presentation of Wilson's disease in a patient after liver transplantation

artículo científico publicado en 2008

Oxidative stress and natural antioxidant mechanisms: the role in neurodegeneration. From molecular mechanisms to therapeutic strategies

artículo científico publicado en 2013

Patients' Perspective And Usefulness Of Pictograms In Short-Term Antibiotic Therapy - Multicenter, Randomized Trial

scientific article published on 02 October 2019

Polymorphisms of metal transporter genes DMT1 and ATP7A in Wilson's disease

artículo científico publicado en 2013

Positivity of serum "classical" onconeural antibodies in a series of 2063 consecutive patients with suspicion of paraneoplastic neurological syndrome.

artículo científico publicado en 2013

Prestroke antihypertensive therapy: effect on the outcome.

artículo científico publicado en 2012

The APOE polymorphism and 1-year outcome in ischemic stroke: genotype-gender interaction

scientific article published on 01 December 2007

The activity of malignancy may determine stroke pattern in cancer patients.

artículo científico publicado en 2015

The effect of gender on brain MRI pathology in Wilson's disease.

artículo científico publicado en 2013

The relationship between immunological parameters with etiopathogenesis and clinical course of stroke

artículo científico publicado en 2000

Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease

scientific article published on 25 December 2013

Wilson's disease in consecutive generations of one family.

artículo científico publicado en 2011

Wilson's disease: does iron metabolism impact phenotypic presentation?

artículo científico publicado en 2012

[Practical usefulness of a donor registry with determined HLA class I antigens--current personal experience]

artículo científico publicado en 1993

[Presence of immune complexes in ischemic stroke]

artículo científico publicado en 1999

Lista de obras de Grażyna Gromadzka

APOE does not predict poor outcome 1 year after ischemic stroke

APOE genotype and serum cholesterol in predicting risk for early death from ischemic stroke in men and women.

APOE ϵ 2 allele is an independent risk factor for vulnerable carotid plaque in ischemic stroke patients

Apolipoprotein E (APOE) gene polymorphism and risk and prognosis in cerebral amyloid angiopathy-related haemorrhage ⬇️

Apolipoprotein E gene (APOE) genotype in Wilson's disease: impact on clinical presentation.

Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals

Association between BDNF-196 G>A and BDNF-270 C>T polymorphisms, BDNF concentration, and rTMS-supported long-term rehabilitation outcome after ischemic stroke.

Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-α polymorphisms with risk and clinical course of multiple sclerosis in a Polish population

Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population

Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease ⬇️

BDNF -270 C>T polymorphisms might be associated with stroke type and BDNF -196 G>A corresponds to early neurological deficit in hemorrhagic stroke

BDNF A196G and C270T gene polymorphisms and susceptibility to multiple sclerosis in the Polish population. Gender differences

Brain metal accumulation in Wilson's disease.

CADASIL patient with extracellular calcium deposits

Ceruloplasmin, hephaestin and zyklopen: the three multicopper oxidases important for human iron metabolism

Clinical features of hemolysis, elevated liver enzymes, and low platelet count syndrome in undiagnosed Wilson disease: report of two cases.

Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications

Difference in iron metabolism may partly explain sex-related variability in the manifestation of Wilson's disease

Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.

Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease.

Dysfunctional proteins in neuropsychiatric disorders: from neurodegeneration to Autism Spectrum Disorders

Echolucent internal carotid artery plaques are a risk factor for stroke

Effect of homeostatic iron regulator protein gene mutation on Wilson's disease clinical manifestation: original data and literature review

Elevated levels of anti-heat shock protein antibodies in patients with cerebral ischemia.

Erratum to: Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease.

Estrogen and cytokines production - the possible cause of gender differences in neurological diseases.

Evaluation of the microplate enzyme-linked assay with isolation of glycoprotein IIb/IIIa from platelet membranes: comparison with immunofluorescent tests and monoclonal antibodies

Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease.

Frequency of His1069Gln and Gly1267Lys mutations in Polish Wilson's disease population

Gender differences in Wilson's disease

Gender differences in neurological disease: role of estrogens and cytokines

Gene variants encoding proteins involved in antioxidant defense system and the clinical expression of Wilson disease

Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson's disease

Heterozygous carriers for Wilson's disease--magnetic spectroscopy changes in the brain.

IL1RN intron 2 polymorphism caused by variable number tandem repeats is associated with 1-year outcome in patients with ischaemic stroke.

Impact of BDNF -196 G>A and BDNF -270 C>T polymorphisms on stroke rehabilitation outcome: sex and age differences.

Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus

Infections and ischemic stroke outcome.

Influence of BDNF polymorphisms on Wilson's disease susceptibility and clinical course

Influence of IL-1RN intron 2 variable number of tandem repeats (VNTR) polymorphism on the age at onset of neuropsychiatric symptoms in Wilson's disease.

Influence of age and gender on cytokine expression in a murine model of Parkinson's disease

Intestinal expression of metal transporters in Wilson's disease.

Late onset Wilson's disease: therapeutic implications

Late-onset Wilson's disease

Liver cirrhosis in patients newly diagnosed with neurological phenotype of Wilson's disease

Long-term effect of high doses glucocorticosteroids on mRNA expression for IL-6 and IL-8 in relapsed multiple sclerosis patients

Middle-aged heterozygous carriers of Wilson's disease do not present with significant phenotypic deviations related to copper metabolism

Monozygotic female twins discordant for phenotype of Wilson's disease

Neurochemical and behavioral characteristics of toxic milk mice: an animal model of Wilson's disease.

Neurological presentation of Wilson's disease in a patient after liver transplantation

Oxidative stress and natural antioxidant mechanisms: the role in neurodegeneration. From molecular mechanisms to therapeutic strategies

Patients' Perspective And Usefulness Of Pictograms In Short-Term Antibiotic Therapy - Multicenter, Randomized Trial

Polymorphisms of metal transporter genes DMT1 and ATP7A in Wilson's disease

Positivity of serum "classical" onconeural antibodies in a series of 2063 consecutive patients with suspicion of paraneoplastic neurological syndrome.

Prestroke antihypertensive therapy: effect on the outcome.

The APOE polymorphism and 1-year outcome in ischemic stroke: genotype-gender interaction

The activity of malignancy may determine stroke pattern in cancer patients.

The effect of gender on brain MRI pathology in Wilson's disease.

The relationship between immunological parameters with etiopathogenesis and clinical course of stroke

Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease

Wilson's disease in consecutive generations of one family.

Wilson's disease: does iron metabolism impact phenotypic presentation?

[Practical usefulness of a donor registry with determined HLA class I antigens--current personal experience]

[Presence of immune complexes in ischemic stroke]